Our education construction project portfolio
Our healthcare construction project portfolio
Our research construction projects portfolio
Our commercial construction project portfolio
Our research construction project portfolio
Barr & Barr logo Home Page Company Profile Barr & Barr Construction Services Our Construction Project Portfolio Company News Careers at Barr & Barr Contact Barr & Barr  
TolerRx Corporation
New Corporate Headquarters & Research Facility
 
CYTYC Corporation
  Dyax Corporation
  Eisai Research Center
  Rockefeller University
  Stryker Orthopaedics
  Transkaryotic Therapies
  TolerRx Corporation
TolerRx, a biopharmaceutical company that develops immuno-logical therapies for the pharmaceutical and biotechnology industries, leased one floor at the 300 Technology Square building in Cambridge, MA. The facility operates as TolerRx’s corporate headquarters and research facility.

The project was fast tracked over 16 weeks. The end date completion required some of the early MEP systems to start under a design support effort. The finished space consists of 40% office and 60% laboratory space. Construction included extensive lab benches, cold rooms, a Rodi and acid neutrali-zation system, fume hoods and compressed air and vacuum systems.
 
   
Architect:  Pacific Cornerstone Architects, Inc.  
   
   
   
   


first image second image third image first image fifth image sixth image seventh image eighth image
Barr & Barr's New York Office Barr & Barr's Massachusetts office Barr & Barr's Connecticut office Barr & Barr's New Jersey office